Response of young, aged and osteoarthritic human articular chondrocytes to inflammatory cytokines: Molecular and cellular aspects

Beatrice Dozin, Laura Camardella, Ranieri Cancedda, Antonello Pietrangelo

Research output: Contribution to journalArticle

112 Citations (Scopus)

Abstract

The aim of this study was to investigate the metabolic properties of human articular chondrocytes derived from young, aged and osteoarthritic subjects and their genetic adaptation to a catabolic challenge (i.e. the inflammatory cytokines interleukin-1α and tumor necrosis factor-α), in the absence or presence of diacerein, a drug potentially useful in osteoarthritis. Chondrocytes in primary culture were analyzed for newly secreted proteins, metalloproteinase synthesis and activity, and production of nitric oxide by-products. Results show that chondrocytes from normal but aged subjects present biochemical properties closer to osteoarthritic-derived cartilage than to normal young cartilage, as indicated by cell morphology, cell proliferation rate and pattern of protein secretion (in particular stromelysin-1 and interstitial collagenase). According to patient age and cartilage physiopathology, chondrocytes secrete increasing amounts of a protein identified by micro-sequencing as chitinase-like protein. Upon exposure to the inflammatory cytokines, chondrocytes, regardless the age or the status of the donor, significantly enhance their production of stromelysin-1, interstitial collagenase, interleukin-6 and interleukin-8. By contrast, the chitinase-like protein is not modulated by the cytokines. The pattern of protein secretion and metalloproteinase activity in chondrocytes from aged subjects appeared to be different from that of young patients, but was highly expressed in osteoarthritic chondrocytes. Diacerein, at therapeutically useful concentrations, consistently counteracts the stimulatory effect of cytokines on newly secreted proteins, metalloproteinase activity and nitric oxide production, whereas a selective nitric oxide blocker alone is ineffective. These data demonstrate that a specific gene program is turned on in cytokine-stimulated chondrocytes, which involves production of proteins engaged in remodeling and destruction of cartilage matrix. Part of these mechanisms appears to be operative also in unstimulated aged chondrocytes. Diacerein largely prevents the metabolic alterations caused by cytokine exposure in human chondrocytes, possibly through its ability to block early intracellular mediators after cytokine stimulation, such as oxygen radicals.

Original languageEnglish
Pages (from-to)449-459
Number of pages11
JournalMatrix Biology
Volume21
Issue number5
DOIs
Publication statusPublished - Aug 2002

Fingerprint

Chondrocytes
Joints
diacetylrhein
Cytokines
Cartilage
Proteins
Metalloproteases
Matrix Metalloproteinase 3
Chitinases
Nitric Oxide
Matrix Metalloproteinase 1
Interleukin-8
Interleukin-1
Osteoarthritis
Interleukin-6
Reactive Oxygen Species
Tumor Necrosis Factor-alpha
Cell Proliferation
Tissue Donors

Keywords

  • Articular chondrocytes
  • Cytokines
  • Diacerein
  • NSAID

ASJC Scopus subject areas

  • Molecular Biology

Cite this

Response of young, aged and osteoarthritic human articular chondrocytes to inflammatory cytokines : Molecular and cellular aspects. / Dozin, Beatrice; Camardella, Laura; Cancedda, Ranieri; Pietrangelo, Antonello.

In: Matrix Biology, Vol. 21, No. 5, 08.2002, p. 449-459.

Research output: Contribution to journalArticle

Dozin, Beatrice ; Camardella, Laura ; Cancedda, Ranieri ; Pietrangelo, Antonello. / Response of young, aged and osteoarthritic human articular chondrocytes to inflammatory cytokines : Molecular and cellular aspects. In: Matrix Biology. 2002 ; Vol. 21, No. 5. pp. 449-459.
@article{97a8c0ce5b1a4ee7b105fb784bbda171,
title = "Response of young, aged and osteoarthritic human articular chondrocytes to inflammatory cytokines: Molecular and cellular aspects",
abstract = "The aim of this study was to investigate the metabolic properties of human articular chondrocytes derived from young, aged and osteoarthritic subjects and their genetic adaptation to a catabolic challenge (i.e. the inflammatory cytokines interleukin-1α and tumor necrosis factor-α), in the absence or presence of diacerein, a drug potentially useful in osteoarthritis. Chondrocytes in primary culture were analyzed for newly secreted proteins, metalloproteinase synthesis and activity, and production of nitric oxide by-products. Results show that chondrocytes from normal but aged subjects present biochemical properties closer to osteoarthritic-derived cartilage than to normal young cartilage, as indicated by cell morphology, cell proliferation rate and pattern of protein secretion (in particular stromelysin-1 and interstitial collagenase). According to patient age and cartilage physiopathology, chondrocytes secrete increasing amounts of a protein identified by micro-sequencing as chitinase-like protein. Upon exposure to the inflammatory cytokines, chondrocytes, regardless the age or the status of the donor, significantly enhance their production of stromelysin-1, interstitial collagenase, interleukin-6 and interleukin-8. By contrast, the chitinase-like protein is not modulated by the cytokines. The pattern of protein secretion and metalloproteinase activity in chondrocytes from aged subjects appeared to be different from that of young patients, but was highly expressed in osteoarthritic chondrocytes. Diacerein, at therapeutically useful concentrations, consistently counteracts the stimulatory effect of cytokines on newly secreted proteins, metalloproteinase activity and nitric oxide production, whereas a selective nitric oxide blocker alone is ineffective. These data demonstrate that a specific gene program is turned on in cytokine-stimulated chondrocytes, which involves production of proteins engaged in remodeling and destruction of cartilage matrix. Part of these mechanisms appears to be operative also in unstimulated aged chondrocytes. Diacerein largely prevents the metabolic alterations caused by cytokine exposure in human chondrocytes, possibly through its ability to block early intracellular mediators after cytokine stimulation, such as oxygen radicals.",
keywords = "Articular chondrocytes, Cytokines, Diacerein, NSAID",
author = "Beatrice Dozin and Laura Camardella and Ranieri Cancedda and Antonello Pietrangelo",
year = "2002",
month = "8",
doi = "10.1016/S0945-053X(02)00028-8",
language = "English",
volume = "21",
pages = "449--459",
journal = "Matrix Biology",
issn = "0945-053X",
publisher = "Elsevier B.V.",
number = "5",

}

TY - JOUR

T1 - Response of young, aged and osteoarthritic human articular chondrocytes to inflammatory cytokines

T2 - Molecular and cellular aspects

AU - Dozin, Beatrice

AU - Camardella, Laura

AU - Cancedda, Ranieri

AU - Pietrangelo, Antonello

PY - 2002/8

Y1 - 2002/8

N2 - The aim of this study was to investigate the metabolic properties of human articular chondrocytes derived from young, aged and osteoarthritic subjects and their genetic adaptation to a catabolic challenge (i.e. the inflammatory cytokines interleukin-1α and tumor necrosis factor-α), in the absence or presence of diacerein, a drug potentially useful in osteoarthritis. Chondrocytes in primary culture were analyzed for newly secreted proteins, metalloproteinase synthesis and activity, and production of nitric oxide by-products. Results show that chondrocytes from normal but aged subjects present biochemical properties closer to osteoarthritic-derived cartilage than to normal young cartilage, as indicated by cell morphology, cell proliferation rate and pattern of protein secretion (in particular stromelysin-1 and interstitial collagenase). According to patient age and cartilage physiopathology, chondrocytes secrete increasing amounts of a protein identified by micro-sequencing as chitinase-like protein. Upon exposure to the inflammatory cytokines, chondrocytes, regardless the age or the status of the donor, significantly enhance their production of stromelysin-1, interstitial collagenase, interleukin-6 and interleukin-8. By contrast, the chitinase-like protein is not modulated by the cytokines. The pattern of protein secretion and metalloproteinase activity in chondrocytes from aged subjects appeared to be different from that of young patients, but was highly expressed in osteoarthritic chondrocytes. Diacerein, at therapeutically useful concentrations, consistently counteracts the stimulatory effect of cytokines on newly secreted proteins, metalloproteinase activity and nitric oxide production, whereas a selective nitric oxide blocker alone is ineffective. These data demonstrate that a specific gene program is turned on in cytokine-stimulated chondrocytes, which involves production of proteins engaged in remodeling and destruction of cartilage matrix. Part of these mechanisms appears to be operative also in unstimulated aged chondrocytes. Diacerein largely prevents the metabolic alterations caused by cytokine exposure in human chondrocytes, possibly through its ability to block early intracellular mediators after cytokine stimulation, such as oxygen radicals.

AB - The aim of this study was to investigate the metabolic properties of human articular chondrocytes derived from young, aged and osteoarthritic subjects and their genetic adaptation to a catabolic challenge (i.e. the inflammatory cytokines interleukin-1α and tumor necrosis factor-α), in the absence or presence of diacerein, a drug potentially useful in osteoarthritis. Chondrocytes in primary culture were analyzed for newly secreted proteins, metalloproteinase synthesis and activity, and production of nitric oxide by-products. Results show that chondrocytes from normal but aged subjects present biochemical properties closer to osteoarthritic-derived cartilage than to normal young cartilage, as indicated by cell morphology, cell proliferation rate and pattern of protein secretion (in particular stromelysin-1 and interstitial collagenase). According to patient age and cartilage physiopathology, chondrocytes secrete increasing amounts of a protein identified by micro-sequencing as chitinase-like protein. Upon exposure to the inflammatory cytokines, chondrocytes, regardless the age or the status of the donor, significantly enhance their production of stromelysin-1, interstitial collagenase, interleukin-6 and interleukin-8. By contrast, the chitinase-like protein is not modulated by the cytokines. The pattern of protein secretion and metalloproteinase activity in chondrocytes from aged subjects appeared to be different from that of young patients, but was highly expressed in osteoarthritic chondrocytes. Diacerein, at therapeutically useful concentrations, consistently counteracts the stimulatory effect of cytokines on newly secreted proteins, metalloproteinase activity and nitric oxide production, whereas a selective nitric oxide blocker alone is ineffective. These data demonstrate that a specific gene program is turned on in cytokine-stimulated chondrocytes, which involves production of proteins engaged in remodeling and destruction of cartilage matrix. Part of these mechanisms appears to be operative also in unstimulated aged chondrocytes. Diacerein largely prevents the metabolic alterations caused by cytokine exposure in human chondrocytes, possibly through its ability to block early intracellular mediators after cytokine stimulation, such as oxygen radicals.

KW - Articular chondrocytes

KW - Cytokines

KW - Diacerein

KW - NSAID

UR - http://www.scopus.com/inward/record.url?scp=0036701572&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036701572&partnerID=8YFLogxK

U2 - 10.1016/S0945-053X(02)00028-8

DO - 10.1016/S0945-053X(02)00028-8

M3 - Article

C2 - 12225810

AN - SCOPUS:0036701572

VL - 21

SP - 449

EP - 459

JO - Matrix Biology

JF - Matrix Biology

SN - 0945-053X

IS - 5

ER -